Midas Letter RAW 95: CB1 Capital, Follow The Money Investor Group & Cannabis Commentary 2

Midas Letter RAW 95: CB1 Capital, Follow The Money Investor Group & Cannabis Commentary

Midas Letter RAW highlights the stocks and stories to watch in the Canadian markets today. James West and Ed Milewski provide comprehensive fundamental & technical analysis on all trending business and investment news, while interviewing the top CEOs of all public companies and analysts with the highest reputations in the business.

0:00 – Macroeconomics and Cannabis News and Analysis with James & Ed
-Aphria (TSE:APH) thin strip deal
-Aurora (TSE:ACB); Australis completes Body and Mind Inc deal
-Origin House (OH) releasing Q3 results
-ML indexes review: uniformly up; DOW is up; commodities are down
-Canopy Growth (TSE:WEED) up approx. 6%
-TGOD up 20%; Ed, will meet resistance at $5
-penny stocks tend not to be eligible for your TFSA, above $1 stocks tend to be eligible
-cannot deploy stop-loss on CSE
-ML indexes: if you couldn’t rise today, there’s a problem; Leviathan (EPIC); International Cannabrands (JUJU)

26: 10 – CB1 Capital Management CIO Todd Harrison talks about the impact of the US midterm elections on the cannabis space. Harrison believes the recent market woes for cannabis companies are part of the process of moving from retail to institutional investors and suggests that the medical side of the cannabis industry is an untapped market.

39:00 – FTMIG Co-Founder Brandon Colwell joins James & Ed for macroeconomics and cannabis analysis
-Terra Tech (TRTC) and Golden Leaf (GLH) merger; due diligence on Golden Leaf?
-By buying Golden Leaf, Terra Tech now has Canadian LP (can do all research in Canada, ready for US legalization?); Big amalgamation
-Terra Tech is taking over; non-binding agreement
-Trulieve 937% growth YOY; what happens when they go recreational? don’t need to export if you have that kind of market in the US
-Brandon: dilution for companies like Aurora and Canopy key to staying in the fight with large US companies when US legalizes
-James: more comfortable with tighter share structure; if you’re going to dilute, show that the value is going to go up
-on the medicinal side, it’s going to get swallowed up by Big Pharma
-Rec side: cannabis companies will become subsidiaries of beverage companies; wellness side, will become subsidiaries of cosmetic companies etc
-synthetic cannabinoids (Hyasynth, Ginkgo etc); growing audience for organic products? -why are we taking a natural plant and making it synthetic?
-fractional banking

1:05:25 – Video – Cannabis on Reserve : Cannabis producers are popping up all over Canada, and Indigenous communities are looking to get in on the action. With JB Lauzon.

1:08:14 – Macroeconomics and Cannabis Analysis with James & Ed
-Planet 13 (CNSX:PLTH) up 30% today
-Origin House (OH) in 5 days it’s up 60%
-most of the froth in this market is going to gravitate to Canadian listed US companies
-MPX-iAnthus; iAnthus is one of the great opportunities
-big winners on ML large cap are TGOD, Organigram
-CSE big winners: Isodial up 30%; Chemesis up 29%; Planet 13 up 27%
-small cap winners: In-Med Pharmaceuticals; Emblem Corp; WeedMD up (creating Midas Letter strain)

1:21:45 – Video – “Edmonton Store”: With so few cannabis retail stores in the country, many of us have no idea what to expect. We took a tour of Fire & Flower in Edmonton, to see if it’s all smoke and mirrors. With Liz West.

1:25:05 – Macroeconomics and Cannabis Analysis with James & Ed
-Emblem coming back after losing a lot of value
-mostly green day
-gold: Spearmint Resources (CVE:SRJ)


Check out our website:


SUBSCRIBE to our YouTube:

SUBSCRIBE to our Newsletter:

Download Our Podcast on iTunes:


Follow Us on Twitter:

Like Us on Instagram:

Like Us on Facebook:




Leave a Comment

Your email address will not be published. Required fields are marked *



Click one of our representatives below to chat on WhatsApp or send us an email to [email protected]


× Order Via Whatsapp?